Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

14.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.6K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.7K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.7K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

296
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
296

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting glutamatergic pathways: genetic insights into comorbid neurodevelopmental disorders.

Brain : a journal of neurology·2026
Same author

SCOTCH: isoform-level characterization of gene expression through long-read single-cell RNA sequencing.

Nature communications·2026
Same author

Emergence of a high-risk multidrug-resistant <i>Acinetobacter baumannii</i> clone ST697 in nosocomial settings.

Microbiology spectrum·2026
Same author

Redefining the role of the thiol-based agent <i>N</i>-acetylcysteine in human health and disease and elucidating potential advantages of its amide derivative.

RSC medicinal chemistry·2026
Same author

Circulating amino acids and Type 2 diabetes in a Latin American population-based cohort.

Cardiovascular diabetology·2026
Same author

Multitrait GWAS and functional validation reveal genetic loci for gastric cancer.

Nature communications·2026

Related Experiment Video

Updated: Oct 7, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K

Improved genetic risk scoring algorithm for type 1 diabetes prediction.

Hui-Qi Qu1, Jingchun Qu1, Joseph Glessner1,2,3

  • 1The Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Pediatric Diabetes
|January 8, 2022
PubMed
Summary
This summary is machine-generated.

A genetic risk score (GRS) for type 1 diabetes (T1D) shows promise for predicting T1D risk in African American children. Population-specific thresholds are necessary for accurate risk assessment across diverse groups.

Keywords:
PRSeMERGEgenetic risk scorescreeningtype 1 diabetes

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K

Related Experiment Videos

Last Updated: Oct 7, 2025

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.5K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
06:50

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

2.7K

Area of Science:

  • Genetics
  • Immunology
  • Pediatrics

Background:

  • Accurate type 1 diabetes (T1D) risk prediction aids early intervention and prevention.
  • Genetic risk scoring (GRS) systems, like T1D-GRS2, are being developed for T1D risk assessment.
  • Trans-ethnic GRS may mitigate health disparities caused by limited genomic data in minority populations.

Purpose of the Study:

  • To validate the T1D-GRS2 calculator in diverse pediatric cohorts.
  • To assess the applicability of T1D-GRS2 in African American and European American children.
  • To determine if population-specific thresholds are required for T1D risk prediction.

Main Methods:

  • Validation of the T1D-GRS2 calculator.
  • Utilized two independent cohorts: African American and European American children.
  • Data sourced from the Center for Applied Genomics at the Children's Hospital of Philadelphia.

Main Results:

  • The T1D-GRS2 demonstrated applicability for T1D risk prediction in the African American cohort.
  • Population-specific thresholds were found to be necessary for accurate risk prediction in different ethnic groups.
  • The study confirmed the utility of GRS in diverse populations.

Conclusions:

  • The T1D-GRS2 is a valuable tool for predicting type 1 diabetes risk across different ancestries.
  • Implementing population-specific thresholds enhances the accuracy of T1D-GRS2 predictions.
  • Future improvements in T1D-GRS2 performance are possible with the integration of additional genetic markers.